ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 186 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,891,181 | -41.7% | 67,020 | -33.4% | 0.20% | -2.0% |
| Q3 2016 | $6,676,000 | -30.9% | 100,615 | -34.8% | 0.20% | -13.3% |
| Q1 2015 | $9,658,000 | +24.2% | 154,401 | +12.0% | 0.23% | +16.5% |
| Q4 2014 | $7,776,000 | +38.3% | 137,901 | -23.1% | 0.20% | +25.0% |
| Q3 2014 | $5,621,000 | -10.1% | 179,295 | -1.3% | 0.16% | -7.0% |
| Q2 2014 | $6,254,000 | +11.3% | 181,595 | +1.3% | 0.17% | +7.5% |
| Q1 2014 | $5,621,000 | – | 179,295 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |